COVID-19 Recurrence After Paxlovid Treatment Not Likely Due to Resistance, Impaired Immunity - Infectious Disease Advisor

Researchers assessed whether treatment resistance or impaired humoral immunity were associated with the recurrence of COVID-19 infection following treatment with Paxlovid.

Neither treatment resistance nor a lack of neutralizing immunity were likely causes of recurrent COVID-19 infection in a patient who had received treatment with Paxlovid (nirmatrelvir/ritonavir), acc… [+2911 chars]

full article...